Trials / Completed
CompletedNCT04703998
Arthroscopic Rotator Cuff Repair Augmented With Platelet Rich Plasma
Arthroscopic Rotator Cuff Repair Augmented With Platelet Rich Plasma. Prospective Randomized Controlled Trial.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 103 (actual)
- Sponsor
- Hospital Italiano de Buenos Aires · Academic / Other
- Sex
- All
- Age
- 50 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Purpose: To assess whether the use of platelet-rich plasma used as an adjuvant to arthroscopic rotator cuff repairs modify the rate of re-tears (measured by MRI) compared to a control group that only underwent the isolated arthroscopic repair. Hypothesis: Platelet rich plasma used as an adjuvant to arthroscopic rotator cuff repairs decrease the rate of retears.
Detailed description
Platelet-rich plasma used as an adjuvant to arthroscopic rotator cuff repairs modify the rate of re-tears (measured by MRI) compared to a control group that only underwent the isolated arthroscopic repair.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Arthroscopic rotator cuff repair | A double-row rotator cuff repair will be performed. |
| BIOLOGICAL | platelet rich plasma | A single dose of 10 ml of autologous platelet rich plasma at the bone-tendon interfase will be administered. |
Timeline
- Start date
- 2021-01-03
- Primary completion
- 2022-09-01
- Completion
- 2022-09-01
- First posted
- 2021-01-11
- Last updated
- 2022-12-22
Locations
1 site across 1 country: Argentina
Source: ClinicalTrials.gov record NCT04703998. Inclusion in this directory is not an endorsement.